[go: up one dir, main page]

HRP20020988B1 - Compounds for treating impaired fundic relaxation - Google Patents

Compounds for treating impaired fundic relaxation

Info

Publication number
HRP20020988B1
HRP20020988B1 HR20020988A HRP20020988A HRP20020988B1 HR P20020988 B1 HRP20020988 B1 HR P20020988B1 HR 20020988 A HR20020988 A HR 20020988A HR P20020988 A HRP20020988 A HR P20020988A HR P20020988 B1 HRP20020988 B1 HR P20020988B1
Authority
HR
Croatia
Prior art keywords
alkyl
alkyloxy
hydroxy
alkyloxycarbonyloxy
aminocarbonyl
Prior art date
Application number
HR20020988A
Other languages
English (en)
Croatian (hr)
Inventor
Van Emelen Kristof
Frans Leopold De Bruyn Marcel
Jesus Alcazar-Vaca Manuel
Ignacio Andres-Gil Jose
Javier Fernandez-Gadea Francisco
Encarnacion Matesanz-Ballesteros Maria
Manuel Bartolome-Nebreda Jose
Original Assignee
Janssen Pharmaceutica N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica N.V. filed Critical Janssen Pharmaceutica N.V.
Publication of HRP20020988A2 publication Critical patent/HRP20020988A2/hr
Publication of HRP20020988B1 publication Critical patent/HRP20020988B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D411/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D411/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
HR20020988A 2000-06-22 2001-06-13 Compounds for treating impaired fundic relaxation HRP20020988B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00202180 2000-06-22
PCT/EP2001/006749 WO2001098306A1 (en) 2000-06-22 2001-06-13 Compounds for treating impaired fundic relaxation

Publications (2)

Publication Number Publication Date
HRP20020988A2 HRP20020988A2 (en) 2005-02-28
HRP20020988B1 true HRP20020988B1 (en) 2011-06-30

Family

ID=8171674

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20020988A HRP20020988B1 (en) 2000-06-22 2001-06-13 Compounds for treating impaired fundic relaxation

Country Status (33)

Country Link
US (2) US7081453B2 (is)
EP (1) EP1296987B1 (is)
JP (1) JP4911860B2 (is)
KR (1) KR100821107B1 (is)
CN (2) CN100516066C (is)
AR (1) AR032158A1 (is)
AT (1) ATE312104T1 (is)
AU (1) AU783292B2 (is)
BG (1) BG65895B1 (is)
BR (1) BR0111859B1 (is)
CA (1) CA2410233C (is)
CZ (1) CZ305005B6 (is)
DE (1) DE60115647T2 (is)
EA (1) EA005760B1 (is)
EE (1) EE04878B1 (is)
EG (1) EG24462A (is)
ES (1) ES2254467T3 (is)
HR (1) HRP20020988B1 (is)
HU (1) HU227398B1 (is)
IL (2) IL153559A0 (is)
IS (1) IS2618B (is)
JO (1) JO2352B1 (is)
MX (1) MXPA02012844A (is)
MY (1) MY155267A (is)
NO (1) NO328547B1 (is)
NZ (1) NZ522519A (is)
PA (1) PA8519601A1 (is)
PL (1) PL201656B1 (is)
SA (1) SA01220442B1 (is)
SK (1) SK287730B6 (is)
UA (1) UA74576C2 (is)
WO (1) WO2001098306A1 (is)
ZA (1) ZA200210303B (is)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20010868A2 (en) * 1999-06-02 2003-04-30 Janssen Pharmaceutica Nv Aminoalkyl substituted (benzodioxan, benzofuran or benzopyran) derivatives
EA004648B1 (ru) 1999-06-02 2004-06-24 Янссен Фармацевтика Н.В. Пирролидинил-, пиперидинил- или гомопиперидинилзамещенные производные, способ их получения, их применение в медицине, содержащая их фармацевтическая композиция и способ ее получения
JO2352B1 (en) * 2000-06-22 2006-12-12 جانسين فارماسيوتيكا ان. في Compounds for the treatment of non-adaptation of the bottom of the uterus
JO2654B1 (en) * 2000-09-04 2012-06-17 شركة جانسين فارماسوتيكا ان. في Multiple aryl caroxa amides are useful as lipid - lowering agents
JO2409B1 (en) * 2000-11-21 2007-06-17 شركة جانسين فارماسوتيكا ان. في Second-phenyl carboxy amides are useful as lipid-lowering agents
HRP20160180T1 (hr) 2003-04-24 2016-03-25 Incyte Holdings Corp Derivati aza spiro alkana kao inhibitori metaloproteaza
JP4896476B2 (ja) * 2005-09-16 2012-03-14 広栄化学工業株式会社 メチルオキシメチルアミノピリジン誘導体及びその製造方法
US7999107B2 (en) 2007-01-31 2011-08-16 Merck Sharp & Dohme Corp. Substituted pyrano[2,3-B]pyridine derivatives as cannabinoid-1 receptor modulators
NZ580801A (en) * 2007-05-10 2012-09-28 Bristol Myers Squibb Co Aryl- and heteroaryl-substituted tetrahydrobenzo-1,4-diazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
CN103917529B (zh) 2011-11-11 2016-08-17 辉瑞大药厂 2-硫代嘧啶酮类
MA42035A (fr) 2015-05-05 2018-03-14 Pfizer 2-thiopyrimidinones
CN105481839B (zh) * 2015-11-23 2018-05-11 安徽千和新材料科技发展有限公司 一种光活性环氧啉对映体的制备方法
EP3229193A1 (en) 2016-04-07 2017-10-11 The Boeing Company A computer-implemented method and system for sharing information between passengers and air traffic management stakeholders

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3910930A (en) * 1973-01-04 1975-10-07 Janssen Pharmaceutica Nv 1-{55 1-{8 2-(1,4-Benzodioxan-2-yl)-2-hydroxyethyl{9 -4-piperidyl{56 -2-benzimidazolinones
EP0004358A1 (de) * 1978-03-20 1979-10-03 Ciba-Geigy Ag N-Oxacyclyl-alkyl-piperidine, Verfahren zu ihrer Herstellung, pharmazeutische Präparate enthaltend diese Verbindungen
WO1993017017A1 (en) * 1992-02-27 1993-09-02 Janssen Pharmaceutica N.V. [(benzodioxan, benzofuran or benzopyran)-alkylamino] alkyl substituted guanidines as selective vascoconstrictors
WO1997028157A1 (fr) * 1996-02-01 1997-08-07 Pierre Fabre Medicament Nouveaux derives de la piperidine substitues en position 4 par un groupe imidazolidin-2-on-1-yl-ethyl, tetrahydropyrimidin-2-on-1-yl-ethyl, et 1,3-dia-zepin-2-on-1-yl-ethyl, et leurs applications comme antagonistes des recepteurs alpha-2 adrenergiques
WO1999029687A1 (en) * 1997-12-05 1999-06-17 Janssen Pharmaceutica N.V. (benzodioxan, benzofuran or benzopyran) derivatives having fundic relaxation properties
WO2000075137A1 (en) * 1999-06-02 2000-12-14 Janssen Pharmaceutica N.V. Pyrrolidinyl, piperidinyl or homopiperidinyl substituted (benzodioxan, benzofuran or benzopyran) derivatives
WO2000075136A1 (en) * 1999-06-02 2000-12-14 Janssen Pharmaceutica N.V. Aminoalkyl substituted (benzodioxan, benzofuran or benzopyran) derivatives

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2400049A1 (de) * 1974-01-02 1975-07-10 Spumalit Anstalt Transportkasten aus kunststoff, insbesondere fuer flaschen
US4329348A (en) * 1979-02-26 1982-05-11 Ciba-Geigy Corporation N-Oxacyclic-alkylpiperidines as psychostimulants
DE3484096D1 (de) * 1983-11-30 1991-03-14 Janssen Pharmaceutica Nv Bizyklisches heterozyklyl aufveisende n-(bizyklisches heterozyklyl-4-piperidinamine.
CA2090767A1 (en) 1992-03-06 1993-09-07 Gerald Guillaumet 1,4-dioxino[2,3-b]pyridine derivatives
US6403103B1 (en) * 1994-08-12 2002-06-11 Bio Merieux Trypanosoma cruzi antigen, gene encoding therefore, and methods of detecting and treating chagas disease
TWI225488B (en) * 1999-12-21 2004-12-21 Janssen Pharmaceutica Nv Derivatives of homopiperidinyl substituted benzimidazole analogues
JO2352B1 (en) * 2000-06-22 2006-12-12 جانسين فارماسيوتيكا ان. في Compounds for the treatment of non-adaptation of the bottom of the uterus

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3910930A (en) * 1973-01-04 1975-10-07 Janssen Pharmaceutica Nv 1-{55 1-{8 2-(1,4-Benzodioxan-2-yl)-2-hydroxyethyl{9 -4-piperidyl{56 -2-benzimidazolinones
EP0004358A1 (de) * 1978-03-20 1979-10-03 Ciba-Geigy Ag N-Oxacyclyl-alkyl-piperidine, Verfahren zu ihrer Herstellung, pharmazeutische Präparate enthaltend diese Verbindungen
WO1993017017A1 (en) * 1992-02-27 1993-09-02 Janssen Pharmaceutica N.V. [(benzodioxan, benzofuran or benzopyran)-alkylamino] alkyl substituted guanidines as selective vascoconstrictors
WO1997028157A1 (fr) * 1996-02-01 1997-08-07 Pierre Fabre Medicament Nouveaux derives de la piperidine substitues en position 4 par un groupe imidazolidin-2-on-1-yl-ethyl, tetrahydropyrimidin-2-on-1-yl-ethyl, et 1,3-dia-zepin-2-on-1-yl-ethyl, et leurs applications comme antagonistes des recepteurs alpha-2 adrenergiques
WO1999029687A1 (en) * 1997-12-05 1999-06-17 Janssen Pharmaceutica N.V. (benzodioxan, benzofuran or benzopyran) derivatives having fundic relaxation properties
WO2000075137A1 (en) * 1999-06-02 2000-12-14 Janssen Pharmaceutica N.V. Pyrrolidinyl, piperidinyl or homopiperidinyl substituted (benzodioxan, benzofuran or benzopyran) derivatives
WO2000075136A1 (en) * 1999-06-02 2000-12-14 Janssen Pharmaceutica N.V. Aminoalkyl substituted (benzodioxan, benzofuran or benzopyran) derivatives

Also Published As

Publication number Publication date
JO2352B1 (en) 2006-12-12
DE60115647T2 (de) 2006-08-24
MXPA02012844A (es) 2003-05-15
HUP0301185A3 (en) 2009-03-30
HRP20020988A2 (en) 2005-02-28
CA2410233A1 (en) 2001-12-27
UA74576C2 (en) 2006-01-16
AU8386401A (en) 2002-01-02
PL201656B1 (pl) 2009-04-30
KR100821107B1 (ko) 2008-04-14
NO328547B1 (no) 2010-03-15
AU783292B2 (en) 2005-10-13
HU227398B1 (hu) 2011-05-30
JP4911860B2 (ja) 2012-04-04
EG24462A (en) 2009-07-16
BR0111859A (pt) 2003-05-13
SK287730B6 (en) 2011-07-06
US7081453B2 (en) 2006-07-25
IL153559A0 (en) 2003-07-06
IS6591A (is) 2002-10-25
BR0111859B1 (pt) 2015-01-06
BG107313A (bg) 2003-06-30
EP1296987B1 (en) 2005-12-07
PL358886A1 (en) 2004-08-23
EA005760B1 (ru) 2005-06-30
DE60115647D1 (de) 2006-01-12
AR032158A1 (es) 2003-10-29
HK1057896A1 (en) 2004-04-23
CZ305005B6 (cs) 2015-03-25
CN1288157C (zh) 2006-12-06
CN100516066C (zh) 2009-07-22
SA01220442B1 (ar) 2008-05-21
CA2410233C (en) 2011-01-25
IL153559A (en) 2008-03-20
CN1781921A (zh) 2006-06-07
US20040019051A1 (en) 2004-01-29
CN1437602A (zh) 2003-08-20
ES2254467T3 (es) 2006-06-16
WO2001098306A1 (en) 2001-12-27
NZ522519A (en) 2003-09-26
ATE312104T1 (de) 2005-12-15
NO20026219D0 (no) 2002-12-23
EA200300049A1 (ru) 2003-04-24
JP2004501157A (ja) 2004-01-15
EE04878B1 (et) 2007-08-15
CZ2003115A3 (cs) 2003-06-18
IS2618B (is) 2010-04-15
BG65895B1 (bg) 2010-04-30
EE200200694A (et) 2004-06-15
MY155267A (en) 2015-09-30
HUP0301185A2 (hu) 2003-08-28
SK492003A3 (en) 2003-07-01
NO20026219L (no) 2003-02-17
US7423048B2 (en) 2008-09-09
ZA200210303B (en) 2004-03-19
KR20030007566A (ko) 2003-01-23
PA8519601A1 (es) 2002-08-26
EP1296987A1 (en) 2003-04-02
US20060142318A1 (en) 2006-06-29

Similar Documents

Publication Publication Date Title
HRP20020988B1 (en) Compounds for treating impaired fundic relaxation
IS6565A (is) Trópan afleiður nytsamlegar í meðferð
CY1106522T1 (el) Ετepοκυκλικη ενωση και αντικαρκινικο μεσο που πepιεχει την ιδια ως δραστικο συστατικο
AP1753A (en) Thiophene derivatives as antiviral agents for flavvivirus infection
IL147651A0 (en) Isoxazoline derivative and herbicide containing the same as the active ingredient
ATE275134T1 (de) 4-oxo-1,4-dihydro-3-chinolincarboxamide als antivirale mittel
DE60117839D1 (de) Pyridinon und pyridinethion-derivate mit hiv-hemmenden eigenschaften
DE602004031258D1 (de) Polycyclische mittel zur behandlung von infektione
ATE302775T1 (de) Carbolinderivate
HRP20090162T1 (en) Quinolinone-carboxamide compounds as 5-ht4 receptor agonists
HUP0401303A2 (hu) Fungicid hatással rendelkező jódbenzopirán-4-on-származékok, előállításuk, alkalmazásuk és ilyeneket tartalmazó készítmények
HUP0301607A2 (hu) Szelektív neurokinin antagonista hatású nitrogéntartalmú heterociklusos vegyületek, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
DE60121461D1 (de) Kondensierte pyridoindolderivate
ATE377001T1 (de) Pleuromutilinderivate als antimikrobielle mittel
DE60024471D1 (de) Benzopyran derivate
ATE346067T1 (de) Carbolinderivate
DE60112960D1 (de) Kondensierte pyridoindolderivate
DE60121587D1 (de) Zyklische gmp-spezifische phosphodiesteraseinhibitoren
EP1357124A4 (en) HETEROCYCLIC COMPOUNDS AND COMPOSITIONS IMPROVING CEREBRAL FUNCTIONS CONTAINING THESE AS ACTIVE INGREDIENTS
ATE330958T1 (de) Pyrazino 1'2':1,6öpyrido 3,4-böindolderivate
ES2173120T3 (es) Compuestos de cefem.
MXPA01013148A (es) Nuevos derivados de amonio cuaternario, metodo para la preparacion de los mismos y uso farmaceutico.
HUP9901104A2 (hu) (4-Pirazolil)-karbonil-heteroaril-származékok, előállításuk és alkalmazásuk, a vegyületeket hatóanyagként tartalmazó herbicid készítmények
DE60144246D1 (de) Imidazolderivate, verfahren zu deren herstellung und deren verwendung
WO2006126729A3 (en) Agent for permanent hair waving containing heterocyclic mercapto compound

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20180524

Year of fee payment: 18

PBON Lapse due to non-payment of renewal fee

Effective date: 20190613